Synthesis of N-1-(indanyloxymethyl) and N-1-(4-hydroxybut-2-enyloxymethyl) analogues of the HIV drugs Emivirine and GCA-186

Monatshefte fur Chemie

Volumn 136, Issue 7, 2005, Pages 1247-1254

  El Brollosy, Nasser R ^a,c   Nielsen, Claus ^b   Pedersen, Erik B ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c Tanta University   (Egypt)

Author keywords

Bioorganic chemistry; Drug research; Emivirine analogues; HIV; Non nucleoside reverse transcriptase inhibitors

Indexed keywords

ANTIINFECTIVE AGENT; DRUG ANALOG; EMIVIRINE; GCA 186; INDAN DERIVATIVE; TNK 651; UNCLASSIFIED DRUG;

ARTICLE; DRUG POTENCY; DRUG RESEARCH; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; REACTION ANALYSIS; SUBSTITUTION REACTION;

EID: 21844439749     PISSN: 00269247     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00706-005-0318-7     Document Type: Article

References (24)

1. Mitsuya H, Weinhold KJ, Fuman PA, St. Clair MH, Lehrman SN, Gallo RC, Bolognesi D, Barry DW, Broder S (1985) Proc Natl Acad USA 82: 7096
2. Mitsuya H, Broder S (1986) Proc Natl Acad USA 83: 1911
3. Yarchoan R, Mitsuya H, Thomas RV, Pluda JM, Hartman NR, Perno CF, Marczyk KS, Allain JP, Johns DG, Broder S (1989) Science 245: 412
4. Hopkins AL, Ren J, Esnouf RM, Willcox BE, Jones EY, Ross C, Miyasaka T, Walker RT, Tanaka H, Stammers DK, Stuart DI (1996) J Med Chem 39: 1589
5. Pedersen OS, Pedersen EB (1999) Antiviral Chem Chemother 10: 285
6. Miyasaka T, Tanaka H, Baba M, Hayakawa H, Walker RT, Balzarini J, de Clercq E (1989) J Med Chem 32: 2507
7. Baba M, Tanaka H, De Clercq E, Pauwels R, Balzarini J, Schols D, Takashima H, Perno CF, Walker RT, Miyasaka T (1989) Biochem Biophys Res Commun 165: 1375
8. Tanaka H, Takashima H, Ubasawa M, Sekiya K, Inouye N, Baba M, Shigeta S, Walker RT, De Clercq E, Miyasaka T (1995) J Med Chem 38: 2860
9. Hopkins AL, Ren J, Tanaka H, Baba M, Okamato M, Stuart DI, Stammers DK (1999) J Med Chem 42: 4500
10. Baba M, Tanaka H, Miyasaka T, Yuasa S, Ubasawa M, Walker RT, de Clercq E (1995) Nucleos Nucleot 14: 575
11. th of January 2002, http://www.tripharm.com
12. Szczech GM, Furman P, Painter GR, Barry DW, Borroto-Esoda K, Grizzle TB, Blum MR, Sommandossi JP, Endoh R, Niwa T, Yamamoto M, Moxham C (2000) Antimicrob Agents Chemother 44: 123
13. Ren JS, Esnouf R, Garman E, Jones Y, Somers D, Ross C, Kirby I, Keeling J, Darby G, Stuart D, Stammers DK (1995) Nat Struct Biol 2: 293
14. Kireev DB, Chretien JJ, Grierson DS, Monneret CA (1997) J Med Chem 40: 4257
15. El-Brollosy NR, Jørgensen PT, Dahan B, Boel AM, Pedersen EB, Nielsen C (2002) J Med Chem 45: 5721
16. El-Brollosy NR, Pedersen EB, Nielsen C (2003) Arch Pharm Pharm Med Chem 336: 236
17. Wamberg M, Pedersen EB, El-Brollosy NR, Nielsen C (2004) Bioorg Med Chem 12: 1141
18. Sørensen ER, El-Brollosy NR, Jørgensen PT, Pedersen EB, Nielsen C, Arch Pharm Pharm Med Chem (in press)
19. Nazaretyan AKh, Torosyan GO, Babayan AT (1985) J Appl Chem USSR 58: 2396
20. Danel K, Larsen E, Pedersen EB (1995) Synthesis 8: 934
21. Harada S, Koyanagi Y, Yamamoto N (1985) Science 229: 563
22. Popovic M, Sarngadharan MG, Reed E, Gallo RC (1984) Science 224: 497
23. Mosmann T (1983) J Immunol Methods 65: 55
24. Richman D, Shih CK, Lowy I, Rose J, Prodanovich P, Goff S, Griffin J (1991) Proc Natl Acad Sci USA 88: 11241